Saturday, Apr 20 2024 | Time 01:22 Hrs(IST)
image
Business EconomyPosted at: May 13 2021 7:24PM


MSN Labs enters into Licensing Agreement with Eli Lilly to launch Baricitinib in India for COVID

Hyderabad, May 13 (UNI) MSN Labs (MSN) on Thursday announced that they have entered into a royalty free, non-exclusive, voluntary license agreement with the US-based Eli Lilly and Company of manufacturing and marketing of baricitinib for COVID-19 in India.
The drug baricitinib has been granted a restricted emergency use approval in India by the Central Drugs Standard Control Organization (CDSCO) for emergency use in combination with Remdesivir for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO), Hyderabad-based Pharmaceutical company MSN Group said in a statement, here.
“This Collaboration with Eli Lilly and Company is a landmark milestone in India’s fight against COVID-19 and will thus help in increasing the availability and affordability of baricitinib," said MSN Group Chairman and Managing Director Dr. MSN Reddy
MSN will be launching the product under the brand name BARIDOZ in two strengths 2 mg & 4mg. MSN has developed the active pharmaceutical ingredient and the formulation of baricitinib in its in-house R&D and manufacturing units.
As part of the COVID treatment range, MSN has already launched FAVILOW (Favipiravir) in the strengths of 200mg, 400mg & 800mg and OSELOW (Oseltamivir) as 75 mg capsules.
MSN Group has nine API and five finished dosage facilities in Hyderabad and the U.S.
UNI KNR GK 1924
Please log in to get detailed story.
Tags: #MSN Labs enters into Licensing Agreement with Eli Lilly to launch Baricitinib in India for COVID
More News

"CSIR-IICT and BHEL partners to advance clean fuel technology: MoU signed on CO2 to DME"

19 Apr 2024 | 7:23 PM

Hyderabad, April 19 (UNI) The Council of Scientific and Industrial Research-Indian Institute of Chemical Technology (CSIR-IICT) and Bharat Heavy Electricals Limited (BHEL) Corporate R&D have forged a partnership to develop technology for capturing and converting carbon dioxide (CO2) to Dimethyl Ether (DME) through direct catalytic conversion.

see more..

Amara Raja Infra Wins Greenko’s 700MWp solar project in AP

19 Apr 2024 | 6:41 PM

Hyderabad, Apr 19 (UNI) Amara Raja Infra Private Limited (ARIPL), part of the $1.75 billion Amara Raja Group, on Friday announced it has secured a solar BoS (Balance of System) project of 500MW/700MWp from Greenko.

see more..
Sensex recovers 600 points on heavy buying on last day of week

Sensex recovers 600 points on heavy buying on last day of week

19 Apr 2024 | 5:34 PM

Mumbai, April 19 (UNI) Snapping a losing streak of last four sessions, the BSE Sensex on Friday bounced back 599.34 points to close at 73088.33 on expectation of minimal escalation of tension between Israel and Iran.

see more..

19 Apr 2024 | 5:24 PM

Mumbai, Apr 19 (UNI) IT major Wipro on Friday reported 7.80% year-on-year dip in consolidated net profit at Rs 2,834.6 crore for January-March quarter (Q4) of the financial year 2023-24.

see more..
Rupee up 8 paise against USD

Rupee up 8 paise against USD

19 Apr 2024 | 5:05 PM

Mumbai, April 19 (UNI) The Rupee on Friday ended positive at 83.47, rising 8 paise against the USD on selling US Dollar by bankers and exporters, dealers at the Foreign exchange said.

see more..
image